A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension
Open Access
- 1 November 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 17 (11) , 1056-1058
- https://doi.org/10.1016/j.amjhyper.2004.06.018
Abstract
Background:. Many patients seek complementary medicine treatments like neutraceuticals for common conditions such as hypertension.Methods:. We conductKeywords
This publication has 0 references indexed in Scilit: